TREA

87736062 - EPI X

Follow

Information

  • Trademark
  • 87736062
  • Serial Number
    87736062
  • Filing Date
    December 27, 2017
    6 years ago
  • Transaction Date
    May 06, 2019
    5 years ago
  • Status Date
    May 06, 2019
    5 years ago
  • Published for Opposition Date
    January 08, 2019
    5 years ago
  • Location Date
    May 06, 2019
    5 years ago
  • Status Code
    605
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    BUTTON, JENNIFER JO
  • Attorney Docket Number
    128026-90901
    Attorney Name
    Margarita Wallach
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
EPI X
Case File Statements
  • GS0011: Biologically compatible polymers, namely, hydrogels used to manufacture polymeric networks used in the manufacture of engineered living tissue for medical, scientific and non-scientific purposes; Media for cell culture for use in the biotechnological industry; Media for cell culture for use in non-medical research laboratories; Biological preparation for use in cell cultures other than for medical or veterinary use; Engineered biological tissues and tissue arrays, namely, human and animal organ, connective, epithelial, muscular, and nervous tissues and tissue arrays, for use in scientific and medical research; Biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; Proteins in raw material form for scientific and medical research
  • GS0051: Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs; Preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs; Tissue-regenerative pharmaceutical preparations; Cells for medical use; Human allograft tissue; Living cells for medical use; Implants of living tissues for guided tissue regeneration; Implants comprising living tissue; Implantable materials of living tissue for use in guided tissue regeneration; Skin grafts; Surgical implants comprised of living tissues; Surgical implants of living tissues grown from stem cells; Transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Living tissues for transplant; Engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, connective, epithelial, muscular, and nervous tissue and organs, for medical purposes; Biological molecules to assist in the development of tissue; Haemostatic gel matrix preparations for treating wounds; Natural biomaterials for augmentation of bone, blood and tissue for medical purposes; Pharmaceutical products for tissue regeneration, for tissue repair, for tissue treatment, whether relating to human or animal tissue; Pharmaceutical preparations for the treatment of bone diseases, for cartilaginous diseases, for vascular diseases, for neuronal degeneration, for degeneration of tendons and ligaments, for retinal degeneration, for renal degeneration, degeneration of soft tissue, for diseases with abnormal cell proliferation; Natural biomaterials for bone filling; Natural biomaterials for filling cartilage; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Biological tissue grafts; Biological bone and skin tissues impregnated with lines of oxygen for tissue engineering applications to increase cell survival in tissue intended for subsequent implantation; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Implantable scaffolds comprising living tissue for maintaining tissue contour; Implants comprising living tissue; Natural biomaterials for augmentation of bone and tissue for medical purposes
Case File Event Statements
  • 5/6/2019 - 5 years ago
    19 - ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION Type: MAB5
  • 5/6/2019 - 5 years ago
    18 - ABANDONMENT - AFTER PUBLICATION Type: ABN5
  • 5/2/2019 - 5 years ago
    17 - TEAS EXPRESS ABANDONMENT RECEIVED Type: EXAR
  • 2/1/2019 - 5 years ago
    16 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 1/8/2019 - 5 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/8/2019 - 5 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/19/2018 - 6 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/2/2018 - 6 years ago
    12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/13/2018 - 6 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/13/2018 - 6 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/9/2018 - 6 years ago
    9 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 11/5/2018 - 6 years ago
    8 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK
  • 11/1/2018 - 6 years ago
    7 - ASSIGNED TO LIE Type: ALIE
  • 4/14/2018 - 6 years ago
    6 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 4/14/2018 - 6 years ago
    5 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 4/14/2018 - 6 years ago
    4 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 4/6/2018 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/12/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 12/30/2017 - 6 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP